Wednesday, September 17, 2025
Home Blog Page 2275

World champion Tamirat Tola will run the Valencia Marathon Trinidad Alfonso

0

The Ethiopian athlete, a recent winner at the World Championships in Eugene, will be one of the big names on the elite men’s list hoping to break the course record

Tamirat Tola will be one of the big names on the elite list for the Valencia Marathon Trinidad Alfonso who will take to the starting line on 4 December with the clear goal of lowering the current best time over the Valencian course, set at 2h03:00 in 2020. This will allow the race to continue climbing up the international marathon rankings, in which it currently holds the fifth best record in history.
The Ethiopian runner, who was recently proclaimed World Marathon champion at the World Athletics Championships in Oregon (USA), will enter the race with this international recognition, but also following a sensational personal best over the distance of 2h03:39, achieved less than a year ago in Amsterdam. Tola is a very robust and versatile athlete, with a short but impressive list of achievements in cross country and on the track. At the World Championships and Olympic Games, he has a silver medal and a bronze medal, respectively, in addition to the latest World Cup gold a few weeks ago.
Tamirat Tola is optimistic regarding the challenge of beating his personal best in Valencia and also about lowering the record for the Valencia course. “It is with great pleasure that I accepted the invitation to run the Valencia Marathon after I gave up running the London Marathon. After the victory at the world championships I had to recover 15 days and this meant that with only 60 days of preparation it was not correct to show up in London. I believe that the Valencia course is one of the fastest in the world and I hope to be able to run my personal best and the race record if all conditions are favourable. See you on December 4th in Valencia”, explains the international athlete.
Tola will be the focus of much of the attention in the city of running, although he will not be the only big international elite name that the Valencia Marathon organisers have lined up to run on 4 December, with other favourites to be revealed in the coming weeks.
Double Ethiopian attraction with the debut of Gidey
In addition, this 42nd Valencia Marathon Trinidad Alfonso will be the stage chosen by his Ethiopian compatriot, the athlete Letesenbet Gidey, to make her debut over the distance of 42,195 metres. The Ethiopian athlete has a special love for Valencia, as two of her four world records have been achieved in the city of running. In fact, both of her performances in Valencia have resulted in a world record.

Togo becomes the first country globally to eliminate four neglected tropical diseases

0

Togo received an outstanding achievement award as the first ever country globally to eliminate four NTDs during the World Health Organization (WHO) Regional Committee for Africa meeting held in Lomé. Between 2011 and 2022, Togo has successfully eliminated dracunculiasis (Guinea worm disease), elephantiasis (lymphatic filariasis), human African trypanosomiasis (sleeping sickness) and trachoma.
NTDs are a group of 20 diseases which are preventable and treatable, but 1.7 billion people around the world still require NTD interventions. Many NTDs debilitate, disfigure and disable. By preventing children from going to school and adults from being able to work, NTDs trap individuals and whole communities in cycles of extreme poverty.
Togo has demonstrated a remarkable record of success. As the first country acknowledged by WHO as having won its fight against four NTDs, it eliminated all four diseases in a span of just eleven years. Togo previously achieved transmission-free status for Guinea worm disease in 2011. In 2017, it became the first country in sub-Saharan Africa to eliminate elephantiasis as a public health problem and, in 2020, became the first African country to achieve the same status with sleeping sickness.

JCR affirms Afreximbank’s long-term issuer rating at A-, with a “Stable” outlook

0

African Export-Import Bank (Afreximbank) has announced that Japan Credit Rating Agency (JCR) has affirmed its long-term issuer rating of A- and maintained the “Stable” outlook. The affirmation of Afreximbank’s issuer rating is testament of the Bank’s ever strengthening credit profile and positions to continue to expand and escalate its interventions in Africa, in whose long-term economic development it plays a pivotal role.
JCR Rating Agency noted, in its assessment, the strategic role that Afreximbank’s current Sixth Strategic Plan (2022-2026) plays towards the Bank’s fulfilment and deliverance of its mandate, as well as its crucial work in support of initiatives aligned with the goals of the African Union (AU). Moreover, JCR identified strong shareholder support for Afreximbank’s operations, citing as evidence the healthy progression of capital increases since 2014 as well as the African Union supported US$6.5 billion General Capital Increase (GCI) approved by the Bank’s Board of Directors in June 2021.

First African-manufactured medicine to prevent malaria approved by WHO

0

Sulfadoxine/pyrimethamine (SP) is a well-tolerated, effective and affordable medicine used to prevent malaria in pregnant women and infants; Nearly all malaria cases and deaths occur in Africa, yet until now, the continent was completely reliant on imported quality-assured SP; This breakthrough responds to the need for local production of quality medicines for use in Africa, a major gap that was critically highlighted when the COVID-19 pandemic left the continent with limited access to vital health products in 2020
Local supply of a medicine used to prevent malaria across Africa received a boost recently, as the World Health Organization (WHO) issued a quality certification to the first African manufacturer of a key antimalarial drug used to prevent infection in pregnant women and children. Called pre-qualification, this certification will enable Kenyan manufacturer Universal Corporation Ltd (UCL) to support regional efforts to combat malaria through local production of high-quality sulfadoxine-pyrimethamine (SP). UCL’s pre-qualification was achieved with funding from global health agency Unitaid and support from MMV.